453 related articles for article (PubMed ID: 16448440)
1. Intra-abdominal desmoid tumor following retroperitoneal lymph node dissection for testicular germ cell tumor.
Lawatsch EJ; Datta MW; Van Tuinen P; Sudakoff GS; Davis NB; Langenstroer P
Int J Urol; 2006 Jan; 13(1):84-6. PubMed ID: 16448440
[TBL] [Abstract][Full Text] [Related]
2. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
3. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
Matsuzaki M; Nakano M; Komatsu H; Ohashi K
Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
Yoon GH; Stein JP; Skinner DG
Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
Stephenson AJ; Tal R; Sheinfeld J
J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
[TBL] [Abstract][Full Text] [Related]
6. Robotic-assisted laparoscopic retroperitoneal lymph node dissection.
Davol P; Sumfest J; Rukstalis D
Urology; 2006 Jan; 67(1):199. PubMed ID: 16413370
[TBL] [Abstract][Full Text] [Related]
7. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
[TBL] [Abstract][Full Text] [Related]
8. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
[TBL] [Abstract][Full Text] [Related]
9. Chylous ascites following retroperitoneal lymphadenectomy for testes cancer.
Link RE; Amin N; Kavoussi LR
Nat Clin Pract Urol; 2006 Apr; 3(4):226-32; quiz 233. PubMed ID: 16607371
[TBL] [Abstract][Full Text] [Related]
10. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Brown JA; Bihrle R; Foster RS
Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic retroperitoneal lymph node dissection after prior open retroperitoneal lymphadenectomy and chemotherapy.
Lima GC; Kohanim S; Rais-Bahrami S; Kavoussi LR
Urology; 2005 Dec; 66(6):1319. PubMed ID: 16360471
[TBL] [Abstract][Full Text] [Related]
12. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
Subramanian VS; Gilligan T; Klein EA
Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
[TBL] [Abstract][Full Text] [Related]
13. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
[TBL] [Abstract][Full Text] [Related]
14. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
15. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
18. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
Chang SS; Smith JA; Girasole C; Baumgartner RG; Roth BJ; Cookson MS
J Urol; 2002 Jul; 168(1):87-92. PubMed ID: 12050498
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
20. [Non-seminoma testicular tumors; results of a treatment method focusing on retroperitoneal lymph node dissection].
Schraffordt Koops H; Eibergen R; Oldhoff J; Van der Ploegen E; Vermey A
Ned Tijdschr Geneeskd; 1978 Jul; 122(28):1020-6. PubMed ID: 209355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
